Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO
26. November 2024 16:05 ET
|
Lifecore Biomedical, Inc.
Three-Year Term Extension Combined with Simplification and Reduction of Interest Rates Helps Further Strengthen Company’s Balance Sheet and Overall Financial Position Builds Upon Other Recent...
Lifecore Biomedical Hosts Virtual Investor Day
21. November 2024 16:17 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical to Present at Stephens Annual Investment Conference
12. November 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
04. November 2024 07:00 ET
|
Lifecore Biomedical, Inc.
Brings Strong Background in Pharmaceutical Manufacturing Operations and Finance to Help Drive Performance and Productivity Jackie Klecker Named Executive Vice President, Quality and Development...
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
04. Oktober 2024 07:30 ET
|
Lifecore Biomedical, Inc.
-- Recorded Revenues of $24.7 Million for Q1 Fiscal 2025 ---- Signed Multiple New Business Agreements with New and Existing Customers ---- More than Doubled Capacity with Installation of 5-Head...
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
03. Oktober 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
25. September 2024 18:18 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lifecore To Contact Him Directly To Discuss Their Options If...
DEADLINE ALERT for LFCR, OM, SAGE, and SMCI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
25. September 2024 12:08 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm
22. September 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
19. September 2024 10:41 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lifecore To Contact Him Directly To Discuss Their Options If...